EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Autoantibodies in Patients With Arrhythmogenic Cardiomyopathy Activate GSK ‐3β, Resulting in a Loss of Cardiomyocyte Cohesion

Soumyata Pathak iD, Konstanze Stangner, Ellen Kempf, Sina Moztarzadeh, Matthias Hiermaier, Stephanie Wider, Marlene Rauschmayer, Tatjana Williams, Andreas Stengl, Brenda Gerull, Ruth Biller, Sebastian Clauss und 4 weitere

Acta Physiologica · 2026-07 · 242 (7)

DOI: 10.1111/apha.70254 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Physiologica, online erschienen am 31.05.2026. Verfasst von Soumyata Pathak und 15 weiteren Autor:innen. Beteiligte Einrichtung: Vegetative Anatomy, Institute of Anatomy, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany. Hauptthemen laut MEDLINE: Myocytes, Cardiac, Autoantibodies, Glycogen Synthase Kinase 3 beta, Arrhythmogenic Right Ventricular Dysplasia. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ludwig-Maximilians-Universität München, Deutsche Forschungsgemeinschaft, Innovative Medicines Initiative.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Arrhythmogenic cardiomyopathy (ACM) is an inherited cardiac desmosome disease, as more than 50% of affected patients carry pathogenic variants in desmosome protein‐coding genes. In this study, we focused on the role and mechanisms of pathogenic and non‐pathogenic autoantibodies against intercalated disc (ICD) proteins such as desmoglein2 (DSG2) in ACM patients, healthy relatives (HR), and murine ACM models. Materials and Methods IgG fractions from ACM patients, HR, healthy controls, and murine ACM models were isolated. Besides ELISA and cleavage assay, dissociation assay, immunostaining, Triton‐X‐100 assay, Western blots, and atomic force microscopy were performed in murine cardiac slices, HL‐1 cells, or induced pluripotent stem cells‐derived cardiomyocytes (hiPSC‐CMs).

Results

IgG fractions from ACM patients and HR, but not murine ACM model‐derived or grouped healthy controls IgG (G‐HC), revealed positive ICD staining. Three out of six ACM patients derived IgGs that reduced cardiomyocyte cohesion. Pathogenic autoantibodies, bound to DSG2 in healthy and ACM hiPSC‐CMs, cleaved and reduced DSG2 interaction at the molecular level. We investigated GSK‐3β contribution to the cardiomyocyte cohesion loss and observed GSK‐3β reduced baseline cohesion in cultured cardiomyocytes and cardiac slices. Among five ACM‐IgGs, three HR‐IgGs tested, three pathogenic ACM‐IgGs activated GSK‐3β upstream of p38MAPK, leading to phosphorylation and junctional loss of β‐catenin. GSK‐3β inhibition rescued the loss of cell cohesion in ACM hiPSC‐CMs.

Conclusion

Pathogenic autoantibodies targeting DSG2 are present in ACM patients and impair cardiomyocyte cohesion in a GSK‐3β‐dependent manner. In contrast, autoantibodies are absent in murine ACM models and are non‐pathogenic in some patients and HR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocytes, CardiacAutoantibodiesGlycogen Synthase Kinase 3 betaArrhythmogenic Right Ventricular DysplasiaAnimalsHumansMiceFemaleMaleDesmoglein 2Cell AdhesionAdultMiddle AgedDisease Models, Animal

Stichwörter der Autor:innen

Desmoglein2DesmoplakinGSK‐3βarrhythmogenic cardiomyopathyautoantibodies

Substanzen

AutoantibodiesGlycogen Synthase Kinase 3 betaDesmoglein 2

Autor:innen und Institutionen

  • Vegetative Anatomy, Institute of Anatomy, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany.
  • Faculty of Biology, Human Biology and BioImaging, LMU Munich, Munich, Germany.
  • Comprehensive Heart Failure Center and Department of Medicine I, University Hospital Würzburg, Würzburg, Germany.
  • ARVC-Selbsthilfe e.V. Patient Association, Munich, Germany.
  • Department of Medicine I, University Hospital Munich, Campus Großhadern, Ludwig-Maximilians University Munich (LMU), Munich, Germany.
  • Interfaculty Center for Endocrine and Cardiovascular Disease Network Modelling and Clinical Transfer (ICONLMU), LMU Munich, Munich, Germany.

ORCID-Profile: Soumyata Pathak

Förderung

  • Ludwig-Maximilians-Universität München
  • Deutsche Forschungsgemeinschaft
  • Innovative Medicines Initiative
  • Universitätsklinikum Köln
  • Köln fortune program

Zitieren

APA

Pathak, S., Stangner, K., Kempf, E., Moztarzadeh, S., Hiermaier, M., Wider, S., Rauschmayer, M., Williams, T., Stengl, A., Gerull, B., Biller, R., Clauss, S., Kääb, S., Šarić, T., Yeruva, S., & Waschke, J. (2026). Autoantibodies in Patients With Arrhythmogenic Cardiomyopathy Activate GSK ‐3β, Resulting in a Loss of Cardiomyocyte Cohesion. Acta Physiologica, 242(7). https://doi.org/10.1111/apha.70254

Vancouver

Pathak S, Stangner K, Kempf E, Moztarzadeh S, Hiermaier M, Wider S, et al. Autoantibodies in Patients With Arrhythmogenic Cardiomyopathy Activate GSK ‐3β, Resulting in a Loss of Cardiomyocyte Cohesion. Acta Physiologica. 2026;242(7). doi:10.1111/apha.70254

BibTeX
@article{Pathak2026,
  author = {Pathak, Soumyata and Stangner, Konstanze and Kempf, Ellen and Moztarzadeh, Sina and Hiermaier, Matthias and Wider, Stephanie and Rauschmayer, Marlene and Williams, Tatjana and Stengl, Andreas and Gerull, Brenda and Biller, Ruth and Clauss, Sebastian and Kääb, Stefan and Šarić, Tomo and Yeruva, Sunil and Waschke, Jens},
  title = {Autoantibodies in Patients With Arrhythmogenic Cardiomyopathy Activate GSK ‐3β, Resulting in a Loss of Cardiomyocyte Cohesion},
  journal = {Acta Physiologica},
  year = {2026},
  volume = {242},
  number = {7},
  doi = {10.1111/apha.70254}
}
Kostenlos starten →